Skip to main content

Table 4 Categorization of patients into nine categories by tumor number and AP-factor and subclassification of BCLC stage B HCC

From: Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification

 

AP-1

AP-2

AP-3

(n)

B1

75.6%

73.7%

45.3%

(145)

(35)

(53)

(57)

B23

57.1%

65.6%

43.0%

(100)

(25)

(27)

(48)

B4over

60.0%

34.7%

21.3%

(52)

(5)

(19)

(28)

(n)

(65)

(99)

(133)

(297)

  1. AP-factor, a product of the serum levels of AFP and PIVKA-II. HCC patients were classified into three groups: AP1 (AFP < 200 ng/ml and PIVKA-II < 100 mAU/ml), AP2 (AFP × PIVKA-II < 105), and AP3 (AFP × PIVKA-II ≥ 105). B1, B23, and B4over were classified by tumor numbers 1, 2 or 3, and ≥4, respectively. Group A comprises B1 or B23 and AP-1 or AP-2. Group B comprises B1 or B23 and AP-3, or B4over and AP-1 or AP-2. Group C comprises B4over and AP-3